Chemical Structure : QL-X-138
CAS No.: 1469988-63-3
货号: PC-63076Not For Human Use, Lab Use Only.
QL-X-138 is a selective and potent BTK/MNK dual kinase inhibitor with IC50 of 8, 107.4, and 26 nM for BTK, MNK1, and MNK2, respectively.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥2980 | In stock | |
| 10 mg | ¥4580 | In stock | |
| 25 mg | Get quote | ||
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
QL-X-138 is a selective and potent BTK/MNK dual kinase inhibitor with IC50 of 8, 107.4, and 26 nM for BTK, MNK1, and MNK2, respectively.
QL-X-138 exhibits covalent binding to BTK and noncovalent binding to MNK.
QL-X-138 enhances the antiproliferative efficacies in vitro against a variety of B-cell cancer cell lines, as well as AML and CLL primary patient cells.
QL-X-138 arrests cell cycle progression and strongly induces apoptosis.
| 分子量 | 421.46 | |
| 分子式 | C25H19N5O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
N-[2-Methyl-5-[2-oxo-9-(1H-pyrazol-4-yl)benzo[h]-1,6-naphthyridin-1(2H)-yl]phenyl]-2-propenamide |
|
1. Wu H, et al. Leukemia. 2016 Jan;30(1):173-81.
2. Wang B, et al. Eur J Med Chem. 2017 Sep 8;137:545-557.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright